Proteus: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 22: Line 22:
etc.
etc.
}}
}}
{{SI}}
{{About1|Proteus infection}}|
 
{{CMG}}
{{EH}}
==Overview==
 
'''''Proteus''''' is a genus of [[Gram-negative]] [[Proteobacteria]], which includes [[pathogens]] responsible for many [[human]] [[urinary tract infection]]s.<ref name=Barron>{{cite book | author = Guentzel MN | title = Escherichia, Klebsiella, Enterobacter, Serratia, Citrobacter, and Proteus. ''In:'' Barron's Medical Microbiology ''(Barron S ''et al'', eds.)| edition = 4th ed. | publisher = Univ of Texas Medical Branch | year = 1996 | id = [http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=mmed.section.1472 (via NCBI Bookshelf)] ISBN 0-9631172-1-1 }}</ref> ''Proteus'' species do not usually ferment [[lactose]], but have shown to be capable lactose fermenters depending on the species in a [[TSI]] test, Triple Sugar Iron. They are [[oxidase]] negative, and [[urease]] positive; some species are [[Motility|motile]].<ref name=Sherris>{{cite book | author = Ryan KJ; Ray CG (editors) | title = Sherris Medical Microbiology | edition = 4th ed. | publisher = McGraw Hill | year = 2004 | id = ISBN 0-8385-8529-9 }}</ref>
'''''Proteus''''' is a genus of [[Gram-negative]] [[Proteobacteria]], which includes [[pathogens]] responsible for many [[human]] [[urinary tract infection]]s.<ref name=Barron>{{cite book | author = Guentzel MN | title = Escherichia, Klebsiella, Enterobacter, Serratia, Citrobacter, and Proteus. ''In:'' Barron's Medical Microbiology ''(Barron S ''et al'', eds.)| edition = 4th ed. | publisher = Univ of Texas Medical Branch | year = 1996 | id = [http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=mmed.section.1472 (via NCBI Bookshelf)] ISBN 0-9631172-1-1 }}</ref> ''Proteus'' species do not usually ferment [[lactose]], but have shown to be capable lactose fermenters depending on the species in a [[TSI]] test, Triple Sugar Iron. They are [[oxidase]] negative, and [[urease]] positive; some species are [[Motility|motile]].<ref name=Sherris>{{cite book | author = Ryan KJ; Ray CG (editors) | title = Sherris Medical Microbiology | edition = 4th ed. | publisher = McGraw Hill | year = 2004 | id = ISBN 0-8385-8529-9 }}</ref>



Revision as of 15:45, 28 January 2016

Proteus infection Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Classification

Causes

Screening

Differentiating Proteus infection from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Proteus infection On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Proteus infection

All Images
infection X-ray X-rays
infection Ultrasound Echo & Ultrasound
infection CT CT Images
infection MRI MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Proteus infection

CDC on Proteus infection

Proteus infection in the news

Blogs on Proteus infection

Directions to Hospitals Treating Proteus infection

Risk calculators and risk factors for Proteus infection

Proteus
Proteus vulgaris growth in MacConkey agar culture plate
Proteus vulgaris growth in MacConkey agar culture plate
Scientific classification
Domain: Bacteria
Phylum: Proteobacteria
Class: Gamma Proteobacteria
Order: Enterobacteriales
Family: Enterobacteriaceae
Genus: Proteus
Hauser 1885
Species

P. mirabilis
P. morganii
Proteus penneri (P. penneri)
P. rettgeri
P. vulgaris
etc.

This page is about clinical aspects of the disease.  For microbiologic aspects of the causative organism(s), see Proteus infection.

|

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Proteus is a genus of Gram-negative Proteobacteria, which includes pathogens responsible for many human urinary tract infections.[1] Proteus species do not usually ferment lactose, but have shown to be capable lactose fermenters depending on the species in a TSI test, Triple Sugar Iron. They are oxidase negative, and urease positive; some species are motile.[2]

Pathogenesis

Three species—P. vulgaris, P. mirabilis, and P. penneri—are opportunistic human pathogens.

Antimicrobial regimen

  • Indole positive Proteus species[3]


Proteus vulgaris
24h old culture
24h old culture
Scientific classification
Kingdom: Bacteria
Phylum: Proteobacteria
Class: Gamma Proteobacteria
Order: Enterobacteriales
Family: Enterobacteriaceae
Genus: Proteus
Species: P. vulgaris
Binomial name
Proteus vulgaris
Hauser 1885

Proteus vulgaris is a rod-shaped, nitrate-reducing, indole+ and catalase-positive, hydrogen sulfide-producing, Gram-negative bacterium that inhabits the intestinal tracts of humans and animals. It can be found in soil, water, and fecal matter. It is grouped with the Enterobacteriaceae and is an opportunistic pathogen of humans. It is known to cause urinary tract infections and wound infections.

The term Proteus signifies changeability of form, as personified in the Homeric poems in Proteus, "the old man of the sea", who tends the sealflocks of Poseidon and has the gift of endless transformation. The first use of the term “Proteus” in bacteriological nomenclature was made by Hauser (1885), who described under this term three types of organisms which he isolated from putrefied meat. One of the three species Hauser identified was Proteus vulgaris, so this organism has a long history in microbiology.

Over the past two decades, the genus Proteus, and in particular P. vulgaris, has undergone a number of major taxonomic revisions. In 1982, P. vulgaris was separated into three biogroups on the basis of indole production. Biogroup one was indole negative and represented a new species, P. penneri, while biogroups two and three remained together as P. vulgaris.

Lab identification

According to laboratory fermentation tests, P. vulgaris ferments glucose and amygdalin, but does not ferment mannitol or lactose. P. vulgaris also tests positive for the methyl red (mixed acid fermentation) test and is also an extremely motile organism.

When P. vulgaris is tested using the API 20E identification system[4] it produces positive results for sulfur reduction, urease production, tryptophan deaminase production, indole production, sometimes positive gelatinase activity, and saccharose fermentation, and negative results for the remainder of the tests on the testing strip.

It is referenced in the Analytical Profile Index using the nine-digit code: 047602157

The optimal growing conditions of this organism is in a facultative anaerobic environment with an average temperature of about 40°C.

The Becton/Dickinson BBL Enterotube II system for identification of members of the family Enterobacteriaceae inoculated with P. vulgaris may yield the following results:

  • Positive for glucose fermentation (with gas production)
  • Negative for lysine and ornithine
  • Positive for hydrogen sulfide production and indole production
  • Negative for adonitol and lactose
  • Negative for arabinose, sorbitol and dulcitol
  • Positive for the phenylalanine test and the Harnstoff urea test

P. vulgaris can test positive or negative for citrate. All combine for a "Biocode ID of 31407" for use in the Interpretation Guide/Computer Coding and Identification System. P. vulgaris can also test urease negative in solid media (such as in Enterotube), but will be urease positive in liquid media. The CCIS code will still identify it with a negative urease test.

Proteus infections

Etiology and epidemiology

  • Nosocomial infections
  • P. mirabilis causes 90% of Proteus infections.
  • P. vulgaris and P. penneri are easily isolated from individuals in long-term care facilities and hospitals and from patients with underlying diseases or compromised immune systems.
  • Patients with recurrent infections, those with structural abnormalities of the urinary tract, those who have had urethral instrumentation, and those whose infections were acquired in the hospital have an increased frequency of infection caused by Proteus and other organisms (e.g., Klebsiella, Enterobacter, Pseudomonas, enterococci, and staphylococci)

Clinical expression

Enterobacteriaceae (of which Proteus is a member) and Pseudomonas species are the micro-organisms most commonly responsible for Gram-negative bacteremia and sepsis.

The presence of the sepsis syndrome associated with a urinary tract infection (UTI) should raise the possibility of urinary tract obstruction. This is especially true of patients who reside in long-term care facilities, who have long-term indwelling urethral catheters, or who have a known history of urethral anatomic abnormalities.

UTI obstruction

Urease production leads to precipitation of organic and inorganic compounds, which leads to struvite stone formation. Struvite stones are composed of a combination of magnesium ammonium phosphate (struvite) and calcium carbonate-apatite. Struvite stone formation can be sustained only when ammonia production is increased and the urine pH is elevated to decrease the solubility of phosphate. Both of these requirements can occur only when urine is infected with a urease-producing organism such as Proteus. Urease metabolizes urea into ammonia and carbon dioxide: urea 2 NH3 + CO2. The ammonia/ammonium buffer pair has a pK of 9.0, resulting in the combination of highly alkaline, ammonia-rich urine.

Symptoms attributable to struvite stones are uncommon. More often, women present with UTI, flank pain, or hematuria, and are found to have a persistently alkaline urine pH (>7.0).

Treatments

Known antibiotics to which P. vulgaris is sensitive:

Ciprofloxacin
Ceftazidime
Netilmicin
Sublactam or cefoperazone
Meropenem
Piperacillin/tazobactam
Unasyn

Antibiotics should be introduced in much higher doses than "normal" when P. vulgaris has infected the sinus or respiratory tissues; for example, ciprofloxacin should be introduced at a level of at least 2000 mg per day orally in such a situation, rather than the "standard" 1000 mg per day.

See also


References

  1. Guentzel MN (1996). Escherichia, Klebsiella, Enterobacter, Serratia, Citrobacter, and Proteus. In: Barron's Medical Microbiology (Barron S et al, eds.) (4th ed. ed.). Univ of Texas Medical Branch. (via NCBI Bookshelf) ISBN 0-9631172-1-1.
  2. Ryan KJ; Ray CG (editors) (2004). Sherris Medical Microbiology (4th ed. ed.). McGraw Hill. ISBN 0-8385-8529-9.
  3. Bartlett, John (2012). Johns Hopkins ABX guide : diagnosis and treatment of infectious diseases. Burlington, MA: Jones and Bartlett Learning. ISBN 978-1449625580.
  4. "API Test Strips". Archived from the original on 7 November 2008.

Template:SIB